Competitor Analysis: HIV Small Molecule Therapeutics

Publisher: La Merie Publishing
Pages: 100
Format: PDF
Product Line:
Competitor Analysis
Product Code: LMCA0013
Release Date: December of 2011

500.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
License:
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitior Analysis: HIV Small Molecule Therapeutics

The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed products and  R&D projects of HIV small molecule therapeutics as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics. In addition, the report lists company-specific product portfolios and R&D pipelines of HIV Small Molecule Therapeutics. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Index

  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
  • Nucleoside Reverse Transcriptase Inhibitor (NRTI)
  • Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
  • HIV Protease Inhibitors
  • HIV Integrase Inhibitors
  • HIV Fusion & Entry Inhibitors
  • HIV Maturation Inhibtors
  • Others
  • Dual Combination Drugs
  • Triple Combination Drugs
  • Quadruple Combination Drugs
  • About La Merie

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table of Contents

  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
  • Nucleoside Reverse Transcriptase Inhibitor (NRTI)
  • Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
  • HIV Protease Inhibitors
  • HIV Integrase Inhibitors
  • HIV Fusion & Entry Inhibitors
  • HIV Maturation Inhibtors
  • Others
  • Dual Combination Drugs
  • Triple Combination Drugs
  • Quadruple Combination Drugs
  • About La Merie



The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top